Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease.
about
Autosomal dominant polycystic kidney disease: the last 3 yearsA polycystin-centric view of cyst formation and disease: the polycystins revisitedPolycystin-1: a master regulator of intersecting cystic pathwaysSpanish guidelines for the management of autosomal dominant polycystic kidney diseasePathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapyExperimental therapies and ongoing clinical trials to slow down progression of ADPKDPolycystic kidney disease - where gene dosage countsImproved Structure and Function in Autosomal Recessive Polycystic Rat Kidneys with Renal Tubular Cell TherapyAutosomal dominant polycystic kidney disease: recent advances in clinical managementA genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formationA non-synonymous mutation in the canine Pkd1 gene is associated with autosomal dominant polycystic kidney disease in Bull Terriers.Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathyPolycystin-1 regulates actin cytoskeleton organization and directional cell migration through a novel PC1-Pacsin 2-N-Wasp complex.PKD2 mutation in an Iranian autosomal dominant polycystic kidney disease family with misleading linkage analysis data.Determinants of renal disease variability in ADPKD.Molecular advances in autosomal dominant polycystic kidney disease.Murine Models of Polycystic Kidney Disease.Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.A missense mutation in PKD1 attenuates the severity of renal diseaseRandomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease.High Resolution Melt analysis for mutation screening in PKD1 and PKD2.Interpretation of array comparative genome hybridization data: a major challenge.Molecular diagnostics for autosomal dominant polycystic kidney diseaseThe cell biology of polycystic kidney diseaseMicroRNAs and Polycystic Kidney Disease.Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing.Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment.Mutations in multiple PKD genes may explain early and severe polycystic kidney disease.Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 families.Clinical utility of PKD2 mutation testing in a polycystic kidney disease cohort attending a specialist nephrology out-patient clinic.Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.Predictors of autosomal dominant polycystic kidney disease progressionKidney: polycystic kidney disease.Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencingAutosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele.Molecular analysis of a consanguineous Iranian polycystic kidney disease family identifies a PKD2 mutation that aids diagnostics.B9D1 is revealed as a novel Meckel syndrome (MKS) gene by targeted exon-enriched next-generation sequencing and deletion analysisImaging-based diagnosis of autosomal dominant polycystic kidney disease.Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease.
P2860
Q24656249-F789FAA9-AB6D-4F24-839D-249005F9D956Q26800974-B897CE53-3C7A-4232-A542-E2A66E9B3692Q26826955-0F72A034-CAA6-4D47-8CEF-EBE2CE12A81BQ26863397-2901E91D-E8AE-4F15-9537-8C522D8B858FQ27000075-FAF1888B-2ED0-432E-B0F7-A650B7655173Q27001230-F57F2DF2-2746-4D46-9BC7-39CFD763A66AQ27012746-FD05766D-3395-4CE7-8BCA-8AE81C288450Q27303409-FFFEC233-DD54-41B0-A38D-FFFB312601E2Q28079782-C1A21DAB-0871-42E2-86C8-105670F6EFEDQ28590393-26BBBF78-2A40-40FD-B58A-0E9D68D98286Q30405682-3FBF7892-5142-4B51-A534-E336429A6865Q30539186-1C3FE546-F6F4-4A61-9697-FED8A14AC784Q30576337-59D23ED1-5181-4412-9100-E3784BA98A1EQ31111757-9484435B-DDB0-429A-8727-17A3003F5338Q33723857-597196DF-CA0C-44FC-8520-4A66E65160A6Q33723862-BC543101-0A78-4246-8C9A-9AA7E0245B41Q33856965-9F42319E-0CB9-49FD-B00D-971F2DA840B7Q33872509-134B89EA-7B47-4476-AC10-06292F0DEDABQ33926310-1C7BCE72-DC62-4E2D-A20F-EFF5614B47D4Q33979298-60FF7DD9-A617-4AED-8F5B-762DAFAF84C9Q34050928-C7ABFD21-3CB3-4160-8D8B-A5D2FEF884E7Q34075129-2E65A271-D9B4-411F-976A-73FAD973E72BQ34100184-4FE7808B-E62F-4833-BEDF-CFC6A1F9809FQ34149966-9F00E84D-4CDC-4711-AE84-879D7FC72C35Q34155498-31774665-B80B-4728-8B75-D70B0EB9C81CQ34181261-B0CCBCC8-E5FD-4714-8CE5-D91C74478596Q34194508-E88BB29D-787D-4F4F-8283-968DF8111FF0Q34228262-68F8284F-D02E-40D9-BE00-0CEC1C117710Q34350444-7498933F-40B8-4D4C-842F-0956E61E21F4Q34366204-5B482B65-4165-47B0-8CF6-9064DDBAAB9AQ34423262-BC5DA9C7-4113-40B9-9DD2-AB14AA8DA6C3Q34427678-D17C12CC-5433-4AE1-9C64-F1095094BB6EQ34436755-A719C83D-2F9C-41C1-BD6C-FA5965DA5599Q34444336-8A1DC0D1-EE5F-4242-B60C-54922D016884Q34467747-5B384737-4BD8-46F2-B5B3-D2A4C7EFE103Q34621895-11C1A3E1-F75C-4C08-A5C4-FFB1260C09DDQ34980440-3147A65D-F0CA-4842-827B-863567F2174FQ35030818-A3530D79-A914-4640-967D-8ABAA6FE7F5CQ35124261-F0AFB6A6-4BA3-48B0-88CC-7735BA5D61B9Q35138042-F56E0D2C-F005-4001-8416-5E93E58592F8
P2860
Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Incompletely penetrant PKD1 al ...... in polycystic kidney disease.
@en
Incompletely penetrant PKD1 al ...... in polycystic kidney disease.
@nl
type
label
Incompletely penetrant PKD1 al ...... in polycystic kidney disease.
@en
Incompletely penetrant PKD1 al ...... in polycystic kidney disease.
@nl
prefLabel
Incompletely penetrant PKD1 al ...... in polycystic kidney disease.
@en
Incompletely penetrant PKD1 al ...... in polycystic kidney disease.
@nl
P2093
P2860
P356
P1433
P1476
Incompletely penetrant PKD1 al ...... in polycystic kidney disease.
@en
P2093
Dominique Chauveau
Katharina Hopp
Lesley Rees
Mark B Consugar
Patrick Niaudet
Peter C Harris
Sandro Rossetti
Sharon W Horsley
Sushmita Roy
T Martin Barratt
P2860
P2888
P304
P356
10.1038/KI.2008.686
P407
P577
2009-01-21T00:00:00Z
P5875
P6179
1009619774